Orodispersible Minitablets of Enalapril in Children With Heart Failure Due to Dilated Cardiomyopathy
Status:
Unknown status
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
Paediatric clinical trial in 50 children, from 1 month to less than 12 years of age,
suffering from heart failure due to dilated cardiomyopathy, to obtain paediatric
pharmacokinetic and pharmacodynamic data of enalapril and its active metabolite enalaprilat
while treated for 8 weeks with enalapril in form of Orodispersible Minitablets (ODMTs), to
describe the dose exposure in this patient population.